FR2100716A1 - - Google Patents

Info

Publication number
FR2100716A1
FR2100716A1 FR7119993A FR7119993A FR2100716A1 FR 2100716 A1 FR2100716 A1 FR 2100716A1 FR 7119993 A FR7119993 A FR 7119993A FR 7119993 A FR7119993 A FR 7119993A FR 2100716 A1 FR2100716 A1 FR 2100716A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7119993A
Other languages
French (fr)
Other versions
FR2100716B1 (enExample
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
STATENS BAKTERIOLOGISKA
Original Assignee
STATENS BAKTERIOLOGISKA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by STATENS BAKTERIOLOGISKA filed Critical STATENS BAKTERIOLOGISKA
Publication of FR2100716A1 publication Critical patent/FR2100716A1/fr
Application granted granted Critical
Publication of FR2100716B1 publication Critical patent/FR2100716B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C07K14/765—Serum albumin, e.g. HSA
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/30—Extraction; Separation; Purification by precipitation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR7119993A 1970-06-02 1971-06-02 Expired FR2100716B1 (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE763270A SE348942B (enExample) 1970-06-02 1970-06-02

Publications (2)

Publication Number Publication Date
FR2100716A1 true FR2100716A1 (enExample) 1972-03-24
FR2100716B1 FR2100716B1 (enExample) 1975-06-06

Family

ID=20271889

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7119993A Expired FR2100716B1 (enExample) 1970-06-02 1971-06-02

Country Status (8)

Country Link
AT (1) AT309678B (enExample)
CA (1) CA960964A (enExample)
CH (1) CH572745A5 (enExample)
DE (1) DE2127159C2 (enExample)
FR (1) FR2100716B1 (enExample)
GB (1) GB1344340A (enExample)
NL (1) NL177599C (enExample)
SE (1) SE348942B (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2500076A1 (de) * 1975-01-02 1976-07-08 Waldemar Schneider Verfahren zur erhoehung der intravenoesvertraeglichkeit von aus blut oder blutprodukten ausgefaellten gammaglobulinen
FR2436604A1 (fr) * 1978-09-19 1980-04-18 Immuno Ag Appareil d'impression avec traitement thermique du papier imprime

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE389596B (sv) * 1974-06-14 1976-11-15 P G S Lindroos Saett att ur en vaetska innehallande blodsubstanser separera jaernfoereningar fran globin
US4124576A (en) * 1976-12-03 1978-11-07 Coval M L Method of producing intravenously injectable gamma globulin
US4315851A (en) 1978-12-29 1982-02-16 Kureha Kagaku Kogyo Kabushiki Kaisha Pharmaceutical composition having antitumor activity
CN102272146A (zh) * 2009-01-13 2011-12-07 通用电气健康护理生物科学股份公司 用带负电的聚合物沉淀生物分子
US8546548B2 (en) 2009-05-27 2013-10-01 Baxter International Inc. Method to produce a highly concentrated immunoglobulin preparation for subcutaneous use
AU2010202125B1 (en) 2010-05-26 2010-09-02 Takeda Pharmaceutical Company Limited A method to produce an immunoglobulin preparation with improved yield
IT1397061B1 (it) 2009-12-28 2012-12-28 Kedrion Spa Nuovo processo di purificazione su scala industriale di gammaglobuline da plasma umano per uso industriale.
US8772462B2 (en) 2010-05-26 2014-07-08 Baxter International Inc. Removal of serine proteases by treatment with finely divided silicon dioxide
US8796430B2 (en) 2010-05-26 2014-08-05 Baxter International Inc. Method to produce an immunoglobulin preparation with improved yield
CA2846599A1 (en) 2011-08-26 2013-03-07 Baxter International Inc. Method for reducing the thromboembolic potential of a plasma-derived immunoglobulin composition
TWI629283B (zh) 2012-02-23 2018-07-11 巴克斯歐塔公司 來自血漿中的免疫球蛋白之ｉ-ｉｖ-１部分沉澱
FI3590960T3 (fi) 2012-02-29 2023-04-25 Takeda Pharmaceuticals Co Perifeeristen hermojen IgG-stimuloitu remyelinaatio
WO2014134070A1 (en) 2013-02-26 2014-09-04 Baxter International Inc. Treatment of central nervous system disorders by intranasal administration of immunoglobulin g
HUE044737T2 (hu) 2013-05-06 2019-11-28 Baxalta Inc Alzheimer-kór szubpopulációk kezelése egyesített immunglubulin G-vel
US20250188120A1 (en) 2022-03-07 2025-06-12 Takeda Pharmaceutical Company Limited Affinity chromatographic production of clinical human igg products

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL286954A (enExample) * 1962-01-03
BE713764A (enExample) * 1967-05-01 1968-09-16 Baxter Travenol Lab
AT275038B (de) * 1967-11-15 1969-10-10 Immuno Ag Verfahren zur Gewinnung von reinem Blutalbumin aus Hämopigmente enthaltenden Proteinlösungen

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2500076A1 (de) * 1975-01-02 1976-07-08 Waldemar Schneider Verfahren zur erhoehung der intravenoesvertraeglichkeit von aus blut oder blutprodukten ausgefaellten gammaglobulinen
FR2436604A1 (fr) * 1978-09-19 1980-04-18 Immuno Ag Appareil d'impression avec traitement thermique du papier imprime

Also Published As

Publication number Publication date
DE2127159C2 (de) 1981-12-24
AT309678B (de) 1973-08-27
NL177599B (nl) 1985-05-17
NL7107529A (enExample) 1971-12-06
SE348942B (enExample) 1972-09-18
CA960964A (en) 1975-01-14
CH572745A5 (enExample) 1976-02-27
DE2127159A1 (de) 1971-12-09
FR2100716B1 (enExample) 1975-06-06
GB1344340A (en) 1974-01-23
NL177599C (nl) 1985-10-16

Similar Documents

Publication Publication Date Title
DE2159186B2 (enExample)
FR2110162A1 (enExample)
FR2100716B1 (enExample)
FR2080555A3 (enExample)
FR2119894A1 (enExample)
FR2119933A2 (enExample)
FR2119993A1 (enExample)
FR2081668B1 (enExample)
FR2080549A1 (enExample)
FR2037447A5 (enExample)
FR2081486A1 (enExample)
FR2081644B3 (enExample)
FR2077096A5 (enExample)
JPS4837974B1 (enExample)
FR2108848A7 (enExample)
FR2124653A5 (enExample)
FR2134068B1 (enExample)
FR2113433A5 (enExample)
FR2113338A5 (enExample)
JPS4834633B1 (enExample)
FR2119888A2 (enExample)
FR2080583B1 (enExample)
FR2080582A7 (enExample)
FR2080230A5 (enExample)
JPS4816733Y1 (enExample)